Primecap Management’s Nektar Therapeutics NKTR Stock Holding History

Primecap Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.1M	Sell	279,150 -1,000	-0.4%	-$56.9K	0.02%	233
2025 Q4	$11.8M	Sell	280,150 -8,900	-3%	-$498K	0.01%	248
2025 Q3	$16.4M	Sell	289,050 -10,668	-4%	-$353K	0.01%	244
2025 Q2	$7.74M	Sell	299,718 -57,254	-16%	-$643K	0.01%	270
2025 Q1	$3.64M	Sell	356,972 -12,387	-3%	-$162K	﹤0.01%	290
2024 Q4	$5.15M	Sell	369,359 -24,805	-6%	-$437K	﹤0.01%	273
2024 Q3	$7.69M	Sell	394,164 -7,200	-2%	-$137K	0.01%	272
2024 Q2	$7.47M	Sell	401,364 -63,079	-14%	-$1.33M	0.01%	267
2024 Q1	$6.51M	Sell	464,443 -2,340	-0.5%	-$24.5K	﹤0.01%	274
2023 Q4	$3.96M	Sell	466,783 -13,083	-3%	-$99.1K	﹤0.01%	292
2023 Q3	$4.29M	Sell	479,866 -63,459	-12%	-$611K	﹤0.01%	289
2023 Q2	$4.69M	Sell	543,325 -222,210	-29%	-$2.37M	﹤0.01%	286
2023 Q1	$8.07M	Sell	765,535 -278,402	-27%	-$8.42M	0.01%	262
2022 Q4	$35.4M	Sell	1,043,937 -50,893	-5%	-$2.46M	0.03%	183
2022 Q3	$52.6M	Sell	1,094,830 -8,591	-0.8%	-$511K	0.05%	171
2022 Q2	$62.9M	Sell	1,103,421 -34,034	-3%	-$2.15M	0.06%	162
2022 Q1	$92M	Sell	1,137,455 -23,373	-2%	-$3.46M	0.07%	158
2021 Q4	$235M	Sell	1,160,828 -37,807	-3%	-$8.2M	0.16%	109
2021 Q3	$323M	Sell	1,198,635 -6,816	-0.6%	-$1.64M	0.23%	93
2021 Q2	$310M	Sell	1,205,451 -5,574	-0.5%	-$1.54M	0.21%	94
2021 Q1	$363M	Sell	1,211,025 -18,335	-1%	-$5.71M	0.25%	87
2020 Q4	$313M	Sell	1,229,360 -28,415	-2%	-$7.34M	0.23%	91
2020 Q3	$313M	Sell	1,257,775 -35,998	-3%	-$11.3M	0.26%	82
2020 Q2	$449M	Sell	1,293,773 -71,755	-5%	-$22.4M	0.39%	64
2020 Q1	$366M	Buy	1,365,528 +26,838	+2%	+$8.3M	0.36%	66
2019 Q4	$433M	Buy	1,338,690 +63,809	+5%	+$18.5M	0.31%	76
2019 Q3	$348M	Buy	1,274,881 +2,186	+0.2%	+$802K	0.28%	86
2019 Q2	$679M	Sell	1,272,695 -17,693	-1%	-$8.87M	0.5%	58
2019 Q1	$650M	Sell	1,290,388 -2,947	-0.2%	-$1.75M	0.48%	60
2018 Q4	$638M	Sell	1,293,335 -50,326	-4%	-$30.4M	0.52%	56
2018 Q3	$1.23B	Sell	1,343,661 -49,867	-4%	-$42.6M	0.83%	39
2018 Q2	$1.02B	Sell	1,393,528 -10,598	-0.8%	-$12.2M	0.76%	41
2018 Q1	$2.24B	Sell	1,404,126 -86,375	-6%	-$111M	1.68%	18
2017 Q4	$1.34B	Sell	1,490,501 -52,314	-3%	-$30.9M	1.02%	28
2017 Q3	$555M	Buy	1,542,815 +1,329	+0.1%	+$416K	0.46%	58
2017 Q2	$452M	Buy	1,541,486 +111,254	+8%	+$32.2M	0.39%	66
2017 Q1	$504M	Buy	1,430,232 +1,153	+0.1%	+$259K	0.46%	60
2016 Q4	$263M	Buy	1,429,079 +95,304	+7%	+$19.4M	0.26%	81
2016 Q3	$344M	Buy	1,333,775 +269	+0%	+$69.3K	0.34%	70
2016 Q2	$285M	Sell	1,333,506 -500	-0%	-$112K	0.3%	75
2016 Q1	$275M	Buy	1,334,006 +15,054	+1%	+$2.89M	0.29%	77
2015 Q4	$333M	Buy	1,318,952 +2,693	+0.2%	+$554K	0.34%	70
2015 Q3	$216M	Buy	1,316,259 +2,467	+0.2%	+$436K	0.24%	86
2015 Q2	$247M	Buy	1,313,792 +10,286	+0.8%	+$1.77M	0.24%	92
2015 Q1	$215M	Buy	1,303,506 +88,454	+7%	+$18.2M	0.21%	95
2014 Q4	$283M	Buy	1,215,052 +5,866	+0.5%	+$1.25M	0.29%	79
2014 Q3	$219M	Buy	1,209,186 +155,567	+15%	+$29.8M	0.23%	88
2014 Q2	$203M	Buy	1,053,619 +18,013	+2%	+$3.19M	0.22%	90
2014 Q1	$188M	Buy	1,035,606 +202,380	+24%	+$40.1M	0.21%	93
2013 Q4	$142M	Buy	833,226 +169,636	+26%	+$27.4M	0.17%	101
2013 Q3	$104M	Buy	663,590 +158,600	+31%	+$29.3M	0.14%	110
2013 Q2	$87.5M	Buy	+504,990	New	+$77.5M	0.13%	110

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return